Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination-Reference-Cited by-同舟云学术

Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination

Published:2017-10 Issue:5 Volume:27 Page:485-491
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Aboudaram Amélie,Modesto Anouchka,Chaltiel Léonor,Gomez-Roca Carlos,Boulinguez Serge,Sibaud Vincent,Delord Jean-Pierre,Chira Ciprian,Delannes Martine,Moyal Elizabeth,Meyer Nicolas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference23 articles.

1. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

2. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N Engl J Med,2015

3. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

4. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated;Demaria;Int J Radiat Oncol Biol Phys,2004

5. Can immunostimulatory agents enhance the abscopal effect of radiotherapy?;Levy;Eur J Cancer,2016

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic modification in radiotherapy and immunotherapy for cancers;Tzu Chi Medical Journal;2024-09-05

2. Immune Response to Molecular Radiotherapy with ¹⁷⁷Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome;Cancer Biotherapy and Radiopharmaceuticals;2024-06-21

3. Local and Systemic Management Options for Melanoma Brain Metastases;The Cancer Journal;2024-03

4. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

5. Extra-cranial radiotherapy in anti-PD-1-treated melanoma patients: A systematic review;EJC Skin Cancer;2024